MIT researchers have developed a new machine learning model that can identify and track blobs of plasma created in controlled nuclear-fusion research, reports Ed Browne for Newsweek. “Fusion research is a complex, multidisciplinary project that requires technologies from many fields,” explains graduate student Woonghee “Harry” Han.

Profs. Daron Acemoglu and David Autor speak with New York Times correspondent Thomas B. Edsall about the forces driving working-class voters towards the Republican party. “Elites are making choices that are not good news for non-college workers,” said Acemoglu. “In fact, they are bad news for most workers.” 

Prof. Kieran Setiya’s new book, “Life is Hard: How Philosophy Can Help Us Find Our Way,” is a “lovely, empathetic book,” writes Boston Globe reporter Meredith Goldstein. In a discussion with Goldstein about self-help and philosophy, Setiya noted that in his view “the ideal form of engagement with philosophy is active rather than passive.”

Prof. Alan Lightman is the host of an upcoming docuseries, Searching: Our Quest for Meaning in the Age of Science, which will premiere on PBS in January. “Lightman’s areas of inquiry are as vast as the universe and as tiny as the smallest particle of matter,” writes Matthew Carey for Deadline. He “brings to his explorations the rigor of a scientist and the artistic sensibility of a poet.”

Postdoctoral fellow Suhas Eswarappa Prameela speaks with Science Careers about how to develop and maintain successful relationships with advisors, mentors, and supervisors. “Faculty members are inundated with multiple administrative, teaching, and service activities, so being proactive, articulating your needs, and clearly communicating hurdles in the lab is key,” notes Prameela.

Landmark Bio, a cell and gene therapy manufacturing company co-founded by MIT and a number of other institutions, is focused on accelerating access to innovative therapies for patients, reports Rowan Walrath for Boston Business Journal. "Landmark's new facility includes laboratory space for research and early-stage drug development, as well as analytics tools,” writes Walrath. 

Vaxxes, a Cambridge startup based on research conducted at MIT and Tufts University, is working toward “the creation of a vaccine that’s easy to use, doesn’t require refrigeration, and releases slowly in the skin for a stronger immune response,” reports Ryan Cross for The Boston Globe.

Writing for The Boston Globe, Prof. Linda Griffith underscores the pressing need to invest in studying women’s health and menstruation science. “These were the attitudes society had about breast cancer decades ago; we didn’t talk about it. But then we finally focused on the science, and overcame the squeamishness about mentioning ‘breasts’ by creating a technical language that could be spoken without hesitation by anyone,” writes Griffith. “We need a similar scientific push for menstruation science, and a comfort level with the language that goes with it. It’s time.”

President L. Rafael Reif speaks with Tech reporters Alex Tang, Eunice Zhang and Eva Ge about his tenure as president and offers advice to MIT’s students. “I honestly think that MIT is like a playground for grown-ups. It’s a place where you can learn and do almost anything you’re interested in,” says Reif. “Undergraduates are going to be here for four years. Learn as much as you can during those four years. Experiment as much as you can. Learn from each other as much as you can.”